Diego Rosso

1.4k total citations · 1 hit paper
22 papers, 852 citations indexed

About

Diego Rosso is a scholar working on Physiology, Surgery and Immunology. According to data from OpenAlex, Diego Rosso has authored 22 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 9 papers in Surgery and 8 papers in Immunology. Recurrent topics in Diego Rosso's work include Histiocytic Disorders and Treatments (15 papers), Genital Health and Disease (6 papers) and Parvovirus B19 Infection Studies (6 papers). Diego Rosso is often cited by papers focused on Histiocytic Disorders and Treatments (15 papers), Genital Health and Disease (6 papers) and Parvovirus B19 Infection Studies (6 papers). Diego Rosso collaborates with scholars based in Argentina, United States and Austria. Diego Rosso's co-authors include Jorge Braier, Jan‐Inge Henter, Milen Minkov, Maurizio Aricò, Stephan Ladisch, Gritta Janka, Kenneth L. McClain, Itziar Astigarraga, Kai Lehmberg and Vasanta Nanduri and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer.

In The Last Decade

Diego Rosso

21 papers receiving 835 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

2017 392 citations AnnaCarin Horne, Maurizio Aricò et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diego Rosso Argentina	13	437	411	388	324	208	22	852
Zhigang Li China	14	319 0.7×	181 0.4×	228 0.6×	122 0.4×	98 0.5×	68	639
Tatiana von Bahr Greenwood Sweden	12	873 2.0×	597 1.5×	670 1.7×	52 0.2×	123 0.6×	21	1.1k
Elena Sieni Italy	17	696 1.6×	422 1.0×	566 1.5×	90 0.3×	58 0.3×	39	855
Olive S. Eckstein United States	9	242 0.6×	175 0.4×	162 0.4×	112 0.3×	65 0.3×	29	411
Naoki Sakata Japan	11	471 1.1×	235 0.6×	387 1.0×	53 0.2×	49 0.2×	44	800
Melissa Hines United States	9	873 2.0×	574 1.4×	670 1.7×	25 0.1×	108 0.5×	19	1.1k
Juana Gil-Herrera Spain	5	502 1.1×	377 0.9×	411 1.1×	23 0.1×	62 0.3×	9	693
U. Gross‐Wieltsch Germany	7	361 0.8×	166 0.4×	262 0.7×	24 0.1×	53 0.3×	9	540
Åke Jakobson Sweden	14	72 0.2×	238 0.6×	72 0.2×	345 1.1×	233 1.1×	29	687
Yoshikazu Ichikawa Japan	12	147 0.3×	68 0.2×	171 0.4×	55 0.2×	74 0.4×	25	578

Countries citing papers authored by Diego Rosso

Since Specialization

Citations

This map shows the geographic impact of Diego Rosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Rosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Rosso more than expected).

Fields of papers citing papers by Diego Rosso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Rosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Rosso. The network helps show where Diego Rosso may publish in the future.

Co-authorship network of co-authors of Diego Rosso

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Rosso. A scholar is included among the top collaborators of Diego Rosso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Rosso. Diego Rosso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Rosso, Diego, et al.. (2024). Increased AXLhigh myeloid cells as pathognomonic marker in Langerhans cell histiocytosis and Langerin expression dependence of mTOR inhibition. Clinical Immunology. 263. 110203–110203. 1 indexed citations

2.

Rosso, Diego, et al.. (2022). Monitoring Circulating CD207+CD1a+ Cells in Langerhans Cell Histiocytosis and Clinical Implications. The Journal of Immunology. 209(2). 270–279. 7 indexed citations

3.

Horne, AnnaCarin, Ida Hed Myrberg, Maurizio Aricò, et al.. (2020). Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study. Blood Advances. 4(15). 3754–3766. 34 indexed citations

4.

Silva, Eugenio Antonio Carrera, et al.. (2017). CD207+CD1a+ cells circulate in pediatric patients with active Langerhans cell histiocytosis. Blood. 130(17). 1898–1902. 20 indexed citations

5.

Braier, Jorge, Diego Rosso, Guadalupe Rey, et al.. (2014). Symptomatic Bone Langerhans Cell Histiocytosis Treated at Diagnosis or After Reactivation With Indomethacin Alone. Journal of Pediatric Hematology/Oncology. 36(5). e280–e284. 21 indexed citations

6.

Braier, Jorge, Diego Rosso, Guadalupe Rey, et al.. (2014). Symptomatic Bone Langerhans Cell Histiocytosis Treated at Diagnosis or After Reactivation With Indomethacin Alone. Journal of Pediatric Hematology/Oncology. Publish Ahead of Print.

7.

Aricò, Maurizio, Itziar Astigarraga, Jorge Braier, et al.. (2014). Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood. British Journal of Haematology. 169(2). 241–248. 19 indexed citations

8.

Braier, Jorge, et al.. (2010). Importance of Multi-lineage Hematologic Involvement and Hypoalbuminemia at Diagnosis in Patients With “Risk-organ” Multi-system Langerhans Cell Histiocytosis. Journal of Pediatric Hematology/Oncology. 32(4). e122–e125. 10 indexed citations

9.

Galluzzo, Laura, et al.. (2009). Bone Marrow Findings at Diagnosis in Patients with Multisystem Langerhans Cell Histiocytosis. Pediatric and Developmental Pathology. 13(2). 101–106. 24 indexed citations

10.

Rosso, Diego, et al.. (2008). [Hematodermic CD4+ CD56+ neoplasm in childhood].. PubMed. 68(2). 147–50. 3 indexed citations

11.

Rey, Guadalupe, et al.. (2007). Reactivation and risk of sequelae in Langerhans cell histiocytosis. Pediatric Blood & Cancer. 48(7). 696–699. 31 indexed citations

12.

Maffía, Paulo C., María Lucila Scimone, Nancy Liliana Tateosian, et al.. (2007). Neutrophil Elastase Converts Human Immature Dendritic Cells into Transforming Growth Factor-β1-Secreting Cells and Reduces Allostimulatory Ability. American Journal Of Pathology. 171(3). 928–937. 45 indexed citations

13.

Rosso, Diego, et al.. (2006). Elevated Serum Levels of the Decoy Receptor Osteoprotegerin in Children with Langerhans Cell Histiocytosis. Pediatric Research. 59(2). 281–286. 10 indexed citations

14.

Braier, Jorge, Antonio Latella, Claudio Castaños, et al.. (2004). Outcome in children with pulmonary Langerhans cell histiocytosis. Pediatric Blood & Cancer. 43(7). 765–769. 58 indexed citations

15.

Minkov, Milen, Nicole Grois, Jorge Braier, et al.. (2003). Immunosuppressive treatment for chemotherapy‐resistant multisystem langerhans cell histiocytosis. Medical and Pediatric Oncology. 40(4). 253–256. 10 indexed citations

16.

Rosso, Diego, et al.. (2003). Serum Levels of Interleukin-1 Receptor Antagonist and Tumor Necrosis Factor-Alpha Are Elevated in Children With Langerhans Cell Histiocytosis. Journal of Pediatric Hematology/Oncology. 25(6). 480–483. 21 indexed citations

17.

Rosso, Diego, et al.. (2002). Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis. British Journal of Haematology. 117(1). 54–58. 26 indexed citations

18.

Felice, Marı́a Sara, Pedro Zubizarreta, Elizabeth M. Alfaro, et al.. (2000). Good outcome of children with acute myeloid leukemia and t(8;21)(q22;q22), even when associated with granulocytic sarcoma. Cancer. 88(8). 1939–1944. 2 indexed citations

19.

Zubizarreta, Pedro, Elizabeth M. Alfaro, Marta S. Gallego, et al.. (2000). Good outcome of children with acute myeloid leukemia and t(8;21)(q22;q22), even when associated with granulocytic sarcoma. Cancer. 88(8). 1939–1944. 33 indexed citations

20.

Braier, Jorge, et al.. (1999). LANGERHANS CELL HISTIOCYTOSIS: Retrospective Evaluation of 123 Patients at a Single Institution. Pediatric Hematology and Oncology. 16(5). 377–385. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact